http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015134854-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_955deaec776415c904d92144c286ec46 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate | 2015-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f21e0d39a5ed0429151dd60d51ef8e37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a78b76037bd5a1043fe2c7e07f41e831 |
| publicationDate | 2015-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015134854-A2 |
| titleOfInvention | Small molecule vif dimerization antagonists as anti-hiv agents and for use as hiv/aids therapeutics |
| abstract | The present invention relates to small molecule Vif dimerizatoin antagonists as anti-HIV agents. The present invention relates to the use of the disclosed small molecules and their derivatives as anti HIV agents that disrupt self association of the viral infectivity factor (Vif) found in HIV and other retroviruses. The present invention also relates to methods of using these agents, including methods of treating HIV infection or AIDS. |
| priorityDate | 2014-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1517.